Skip to content

Author

Shankar Biswas

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Efficacy and cardiovascular safety of lasmiditan in patients with cardiovascular risk factors: A systematic review and meta-analysis with updated synthesis of triptan safety data.

OBJECTIVE This study was conducted to evaluate lasmiditan efficacy and cardiovascular (CV) safety in patients with CV risk factors, and provide an updated synthesis of observational evidence on long-term triptan-related CV outcomes. BACKGROUND Approximately 20% of patients with migraine have CV contraindications to t...

Shankar Biswas, S. Vasireddy, Yashasvi Srivastava et al. · 0 citations
Open access Sep 2026

Parkinson’s disease and chronic kidney disease trends and disparities in the US population aged over 25 years (1999–2023)

Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuronal loss and α-synuclein aggregation, resulting in motor dysfunction and increasing mortality. Chronic kidney disease (CKD), affecting nearly 700 million people worldwide, is associated with systemic inflammation, va...

Raymond Haward, N. Duseja, Harkanwar Sandhu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.